Search for content, post, videos

Category

CMDO

recipharm
0 COMMENT
107 Views
Recipharm manufactures to the Japanese market

Recipharm has entered into a long term agreement with Sato Pharmaceutical for the commercial manufacture and delivery of Emla Patch to Japan. Emla Patch is used as a local anaesthetic product and will be launched under the business area of ethical pharmaceuticals at Sato. Recipharm’s facility in Karlskoga, Sweden will…

recipharm
0 COMMENT
126 Views
Recipharm’s latest investment

Twenty years after its founding, Recipharm has established itself as a global life science firm with a solid base in its home country, Sweden and has become an example of a successful Nordic CDMO company. The firm is now setting out to strengthen its Swedish operations further with a new…

cmc-biologics
0 COMMENT
87 Views
AGC Asahi Glass acquires CMC Biologics

Danish CDMO CMC Biologics and AGC Asahi Glass (AGC), a world-leading manufacturer of glass, chemicals and high-tech materials, have entered into a definitive agreement with CMC Biologics’ shareholders including Monitor Clipper Partners, European Equity Partners and Innoven Partenaires, by which AGC will acquire 100% of CMC Biologics’ shares. “With the…

recipharm
0 COMMENT
44 Views
Recipharm enters new collaboration

Recipharm is entering into a collaboration with Laccure AB for the commercial manufacture and delivery of Laccure Pessary. The new product, which has been developed to help women suffering from bacterial vaginosis, will be manufactured, packaged and distributed globally from Recipharm’s facility in Karlskoga that specialises in the production of…

recipharm
0 COMMENT
41 Views
Recipharm invests in its Italian API facility

Recipharm has announced an investment of over €1.2 million to enhance its small scale GMP active pharmaceutical ingredient (API) development and manufacturing capabilities in Paderno Dugnano, Italy. The investment, which is in response to growing demand for Recipharm’s custom synthesis and early phase API manufacturing capabilities, has seen the opening…

uppsala
0 COMMENT
54 Views
Recipharm to open new GLP bioanalysis laboratory in Uppsala

Recipharm has announced a 5 million SEK investment into a new GLP (Good Laboratory Practice) compliant bioanalysis laboratory at its development facility in Uppsala, Sweden, in response to growing customer demand. The investment will see the opening of a 500 square metre purpose-built facility in November 2016, which will become the…

Thomas-Eldered-Recipharm
0 COMMENT
42 Views
Recipharm creates global CDMO through new acquisitions

Swedish CDMO Recipharm continues to expand. Most recently the company acquired Kemwell’s pharmaceutical CDMO businesses. In February Recipharm acquired privately owned Italian CDMO Mitim, adding important technology in the filling of injectable beta lactams with sales to the US and European markets. The transaction is valued at an enterprise value…

Thomas-Eldered-Recipharm
0 COMMENT
46 Views
Recipharm to acquire Mitim Srl for SEK 640 million

Recipharm AB announces that it has entered into an agreement to acquire Italian CDMO, Mitim Srl adding scale and capabilities to the group. Mitim is currently owned by a private Italian family and is specialised in the filling of injectable beta lactam products. It is located in Brescia close to Recipharm’s existing operations in…

recipharm
0 COMMENT
35 Views
Recipharm makes €40m investment

Recipharm will invest €40m over the next three years to ensure state of-the-art solutions for serialisation processes. The move by the company comes as the announcement of the EU Falsified Medicines Directive (EUFMD) Safety Features Delegated Regulation is released. This means that the serialisation of licensed drug products will be a legal requirement…

curida
0 COMMENT
43 Views
Curida signs agreement with Serviceproduksjon

Norwegian CDMO Curida has signed a framework-agreement with Serviceproduksjon, a subsidary to the Norwegian Pharmace Association. The agreement entails validation of a chemical analytical method for use in analysis of tablets and routine analysis of the particular drug. “Serviceproduksjon received offers from three other contract laboratories and chose Curida based…

Thomas-Eldered-Recipharm
0 COMMENT
47 Views
Recipharm signs agreement with Alcon

Recipharm signs manufacturing agreement with Alcon and acquires facility in France, adding new niche capabilities. Recipharm AB has entered into the previously announced strategic collaboration with Alcon, a Novartis company, and today signed a long term supply agreement whereby Recipharm will manufacture a range of ophthalmic products using Blow Fill Seal technology. As part of…

recipharm
0 COMMENT
38 Views
Recipharm and LIDDS signs contract

Recipharm and LIDDS have signed an exclusive collaboration agreement regarding scale-up of the production process and commercial manufacture of Liproca Depot, LIDDS patented targeted treatment for prostate cancer. The agreement will be an important component for the upcoming Phase IIb study which is planned to start in 2016. In connection…

recipharm
0 COMMENT
42 Views
Recipharm secures €25 million contract

Recipharm has signed an agreement with Daewoong, a Korean based pharmaceutical company with a strong presence in respiratory therapeutics, for a ten year extension of its existing contract, through to 2025, for the manufacture and supply of Erdosteine API. The finished Erdosteine product is manufactured by Daewoong Pharmaceutical at its Korean facilities. Under the terms…